Health In Tech, Inc. (HIT)
0.7201
-0.10
(-12.26%)
USD |
NASDAQ |
Oct 01, 12:44
Health In Tech Research and Development Expense (Quarterly) : 0.8758M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.8758M |
| March 31, 2026 | 0.9204M |
| December 31, 2025 | 0.2131M |
| September 30, 2025 | 0.2358M |
| June 30, 2025 | 0.5826M |
| March 31, 2025 | 0.5377M |
| December 31, 2024 | 0.6337M |
| Date | Value |
|---|---|
| September 30, 2024 | 0.7184M |
| June 30, 2024 | 0.7016M |
| March 31, 2024 | 0.7602M |
| December 31, 2023 | 0.6734M |
| September 30, 2023 | 0.5011M |
| June 30, 2023 | 0.4507M |
| March 31, 2023 | 0.3795M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median